Sign in

CIK 0001228627

  • Non-accelerated filer
  • Smaller reporting company

Opus Genetics, Inc.

Sign in to watch
Ticker
IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
113516358
Phone
+1 984-884-6030
Business address
8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
Former names
Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,211,769
in 7 filings, $50K under 10b5-1 plans

Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 46 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-04-20 Bennett Jean Director Grant or award +24,367 259,019
2026-01-01 Bennett Jean Director Grant or award +21,127 234,652
2025-04-30 Bennett Jean Director Grant or award +79,504 213,525
2025-04-30 Bennett Jean Director Grant or award · Stock Option (Right to Buy) +79,592 79,592
2025-01-02 Bennett Jean Director Grant or award +34,021 134,021
2024-10-22 Bennett Jean Director Grant or award +100,000 100,000
2024-10-22 Bennett Jean Director Grant or award · Stock Option (right to buy) +172,874 172,874

Page 1 of 1 · 7 trades